• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《成釉细胞瘤复发相关因素 158 例回顾性研究》

A Retrospective Study of 158 Cases on the Risk Factors for Recurrence in Ameloblastoma.

机构信息

Department of Stomatology, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, 310003,China.

Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003,China.

出版信息

Int J Med Sci. 2021 Jul 25;18(14):3326-3332. doi: 10.7150/ijms.61500. eCollection 2021.

DOI:10.7150/ijms.61500
PMID:34400902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8364459/
Abstract

Ameloblastoma is an odontogenic tumor occurring in jaws, with local aggressiveness and postoperative recurrence. This study was aim to investigate the clinical and radiographic risk factors for recurrence in ameloblastoma. Patients diagnosed with ameloblastoma between March 2009 and March 2019 were retrospectively analyzed. Clinical and Radiological data and follow-up records were collected. Survival analyses were performed by Kaplan-Meier and log-rank tests, as well as Cox proportional hazards model. One hundred and fifty-eight patients (104 males and 54 females were enrolled. The overall recurrence rate for ameloblastoma was 13.29%, and 10.76% recurred within 5 years. Most of the tumors were located in mandible (86.71%), while the rest 21 cases were in maxilla (13.29%). More than half cases (55.06%) showed multilocular radiolucency, 61 cases (38.61%) showed unilocular radiolucency. Significant differences were found with amelobastoma recurrence rate related to treatment modality, impacted tooth and root resorption (P =0.002, 0.022 and 0.007 respectively). Treatment modality, impacted tooth and root resorption all showed statistically significant associations with the recurrence rate in ameloblastoma. However, due to the limitation of this study, further studies are needed to reveal the true mechanism of ameloblastoma recurrence.

摘要

成釉细胞瘤是一种发生在颌骨的牙源性肿瘤,具有局部侵袭性和术后复发的特点。本研究旨在探讨成釉细胞瘤复发的临床和影像学危险因素。

回顾性分析了 2009 年 3 月至 2019 年 3 月期间诊断为成釉细胞瘤的患者。收集了临床和影像学数据以及随访记录。采用 Kaplan-Meier 和对数秩检验以及 Cox 比例风险模型进行生存分析。

共纳入 158 例患者(104 例男性,54 例女性)。成釉细胞瘤的总体复发率为 13.29%,5 年内复发率为 10.76%。大多数肿瘤位于下颌骨(86.71%),其余 21 例位于上颌骨(13.29%)。超过一半的病例(55.06%)表现为多房性透光性,61 例(38.61%)表现为单房性透光性。治疗方式、埋伏牙和牙根吸收与成釉细胞瘤的复发率有显著差异(P=0.002、0.022 和 0.007)。

治疗方式、埋伏牙和牙根吸收均与成釉细胞瘤的复发率有统计学关联。然而,由于本研究的局限性,需要进一步的研究来揭示成釉细胞瘤复发的真正机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d751/8364459/b3193ae0040b/ijmsv18p3326g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d751/8364459/f6be745f54eb/ijmsv18p3326g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d751/8364459/b3193ae0040b/ijmsv18p3326g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d751/8364459/f6be745f54eb/ijmsv18p3326g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d751/8364459/b3193ae0040b/ijmsv18p3326g002.jpg

相似文献

1
A Retrospective Study of 158 Cases on the Risk Factors for Recurrence in Ameloblastoma.《成釉细胞瘤复发相关因素 158 例回顾性研究》
Int J Med Sci. 2021 Jul 25;18(14):3326-3332. doi: 10.7150/ijms.61500. eCollection 2021.
2
[Ameloblastoma of the jaws. A retrospective analysis from 1994 to 2007].[颌骨成釉细胞瘤。1994年至2007年的回顾性分析]
Rev Stomatol Chir Maxillofac. 2011 Nov;112(5):269-79. doi: 10.1016/j.stomax.2011.05.004. Epub 2011 Jul 13.
3
Peripheral ameloblastoma: biological profile based on 160 cases from the literature.外周性成釉细胞瘤:基于文献中160例病例的生物学特征
Oral Oncol. 2001 Jan;37(1):17-27. doi: 10.1016/s1368-8375(00)00064-6.
4
Factors Associated with Recurrence of Ameloblastoma: A Scoping Review.与成釉细胞瘤复发相关的因素:范围综述。
Head Neck Pathol. 2024 Aug 23;18(1):82. doi: 10.1007/s12105-024-01686-7.
5
Recurrent ameloblastoma of the jaws. A follow-up study.颌骨复发性成釉细胞瘤。一项随访研究。
Int J Oral Maxillofac Surg. 1998 Dec;27(6):456-60. doi: 10.1016/s0901-5027(98)80037-4.
6
Ameloblastoma: biological profile of 3677 cases.成釉细胞瘤:3677例病例的生物学特征
Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):86-99. doi: 10.1016/0964-1955(94)00037-5.
7
Recurrence of multicystic ameloblastoma in soft tissue.软组织中多囊性成釉细胞瘤的复发
Trop Doct. 2004 Apr;34(2):112-4. doi: 10.1177/004947550403400223.
8
A clinical, radiographic, and histologic review of 73 cases of ameloblastoma in an Indian population.对印度人群中73例成釉细胞瘤的临床、影像学和组织学回顾。
Quintessence Int. 2010 May;41(5):e90-100.
9
Ameloblastoma: a surgeon's dilemma.成釉细胞瘤:外科医生的两难困境。
J Oral Maxillofac Surg. 2006 Jul;64(7):1010-4. doi: 10.1016/j.joms.2006.03.022.
10
Clinical profile of ameloblastoma among Filipino patients in Metro Manila hospitals.马尼拉大都会医院菲律宾患者成釉细胞瘤的临床特征
J Philipp Dent Assoc. 1997;49(3):5-19.

引用本文的文献

1
Expression of interleukin 1-alpha, interleukin 6 and CD 10 in predicting recurrence of ameloblastoma.白细胞介素1-α、白细胞介素6和CD10的表达在预测成釉细胞瘤复发中的作用
Discov Oncol. 2025 Jul 22;16(1):1390. doi: 10.1007/s12672-025-03235-2.
2
Clinicopathological and Immunohistochemical Risk Predictors for Ameloblastoma Recurrence.成釉细胞瘤复发的临床病理及免疫组化风险预测指标
Head Neck Pathol. 2025 Feb 17;19(1):22. doi: 10.1007/s12105-024-01743-1.
3
Radiologic Specific Growth Rate of Ameloblastomas: A Clinicopathological Correlation.

本文引用的文献

1
Controversies in ameloblastoma management: evaluation of decision making, based on a retrospective analysis.成釉细胞瘤治疗的争议:基于回顾性分析的决策评估。
Med Oral Patol Oral Cir Bucal. 2021 Mar 1;26(2):e181-e186. doi: 10.4317/medoral.24104.
2
Pulmonary resection for multiple lung metastasis from ameloblastoma: a rare case report and literature review.肺部分切除术治疗造釉细胞瘤肺转移:1 例罕见病例报告及文献复习。
Postgrad Med. 2021 Jan;133(1):117-122. doi: 10.1080/00325481.2020.1829841. Epub 2020 Nov 1.
3
Odontogenic keratocyst and ameloblastoma: radiographic evaluation.
成釉细胞瘤的放射学特定生长率:临床病理相关性
J Oral Pathol Med. 2025 Mar;54(3):161-172. doi: 10.1111/jop.13611. Epub 2025 Jan 30.
4
Classification and prognostic evaluation of ameloblastoma using multiplanar CT imaging: a retrospective analysis.使用多平面CT成像对成釉细胞瘤进行分类和预后评估:一项回顾性分析
BMC Oral Health. 2025 Jan 22;25(1):115. doi: 10.1186/s12903-025-05485-6.
5
Case Report: A Rare Location of Recurrent Ameloblastoma.病例报告:复发性成釉细胞瘤的罕见部位
Clin Case Rep. 2024 Nov 29;12(12):e9656. doi: 10.1002/ccr3.9656. eCollection 2024 Dec.
6
Histone H3K9 Methylation Is Differentially Modified in Odontogenic Cyst and Tumors.组蛋白H3K9甲基化在牙源性囊肿和肿瘤中存在差异修饰。
Eur J Dent. 2025 Jul;19(3):688-696. doi: 10.1055/s-0044-1791681. Epub 2024 Nov 7.
7
Epidemiology of odontogenic tumours and selected cysts diagnosed at a single New Zealand oral pathology centre- A 15-year retrospective study.新西兰单一口腔病理中心诊断的牙源性肿瘤和某些囊肿的流行病学:一项 15 年回顾性研究。
Oral Maxillofac Surg. 2024 Dec;28(4):1595-1603. doi: 10.1007/s10006-024-01290-7. Epub 2024 Aug 30.
8
Factors Associated with Recurrence of Ameloblastoma: A Scoping Review.与成釉细胞瘤复发相关的因素:范围综述。
Head Neck Pathol. 2024 Aug 23;18(1):82. doi: 10.1007/s12105-024-01686-7.
9
Low Detection of High-risk Human Papilloma Virus in Individuals with Ameloblastoma in a Tertiary Hospital in Lagos, Nigeria.在尼日利亚拉各斯的一家三级医院中,牙瘤患者的高危型人乳头瘤病毒检测率较低。
Ann Afr Med. 2024 Jul 1;23(3):406-414. doi: 10.4103/aam.aam_102_23. Epub 2024 Apr 24.
10
Immunohistochemical Expression of Ki-67 and p53 and Their Prognostic Role in Ameloblastoma: A Longitudinal Study.Ki-67和p53的免疫组化表达及其在成釉细胞瘤中的预后作用:一项纵向研究
Oman Med J. 2024 Mar 31;39(2):e607. doi: 10.5001/omj.2024.55. eCollection 2024 Mar.
牙源性角化囊肿和造釉细胞瘤:影像学评估。
Oral Radiol. 2021 Jan;37(1):55-65. doi: 10.1007/s11282-020-00425-2. Epub 2020 Feb 6.
4
Desmoplastic ameloblastoma: a systematic review of the cases reported in the literature.促结缔组织增生型成釉细胞瘤:文献报道病例的系统回顾。
Int J Oral Maxillofac Surg. 2020 Jun;49(6):709-716. doi: 10.1016/j.ijom.2019.11.004. Epub 2019 Dec 4.
5
Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study.成釉细胞瘤复发的危险因素:一项长期随访的回顾性研究。
Int J Oral Maxillofac Surg. 2019 Oct;48(10):1300-1306. doi: 10.1016/j.ijom.2019.04.008. Epub 2019 May 11.
6
Upregulation of eukaryotic translation initiation factor 3 subunit a promotes cell survival in ameloblastoma.真核生物翻译起始因子3亚基a的上调促进成釉细胞瘤中的细胞存活。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Aug;128(2):146-153. doi: 10.1016/j.oooo.2019.02.016. Epub 2019 Feb 22.
7
Global incidence and profile of ameloblastoma: A systematic review and meta-analysis.全球造釉细胞瘤的发病率和特征:系统评价和荟萃分析。
Oral Dis. 2020 Jan;26(1):12-21. doi: 10.1111/odi.13031. Epub 2019 Jan 25.
8
Radical vs conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis.骨内成釉细胞瘤的激进与保守治疗:系统评价和荟萃分析。
Oral Dis. 2019 Oct;25(7):1683-1696. doi: 10.1111/odi.13014. Epub 2019 Jan 1.
9
Is conservative surgery a better choice for the solid/multicystic ameloblastoma than radical surgery regarding recurrence? A systematic review.就复发而言,对于实性/多囊性成釉细胞瘤,保守手术比根治性手术是更好的选择吗?一项系统评价。
Oral Maxillofac Surg. 2018 Dec;22(4):349-356. doi: 10.1007/s10006-018-0715-9. Epub 2018 Sep 6.
10
Biological profile of ameloblastoma and its location in the jaw in 1246 Nigerians.1246 例尼日利亚人口腔造釉细胞瘤的生物学特征及其在颌骨中的分布。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Nov;126(5):424-431. doi: 10.1016/j.oooo.2018.06.014. Epub 2018 Jul 24.